Company / Revenue per Share
REGENXBIO Inc. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$3.44
FY2025
5-year range
$0.94 / $3.44
FY2021-FY2025
Trend
+81.8%
vs FY2024
Sector context
#72 of 154
Health Care
What the data says
At $3.44, REGENXBIO Inc.'s revenue per share ranks #72 of 154 in the Health Care sector. Revenue per Share returned to growth in FY2025 after 2 years of decline, reaching $3.44.
Based on SEC 10-K filings.
3.44 in FY2025 with a 5-year CAGR of -10.2%.
Improved from $2.08 to $3.44 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +9.3%
- 5-Year CAGR
- -10.2%
- 10-Year CAGR
- -
Sector benchmark
#72 of 154 in Health CareTop 47% of 154This company $3.44 Sector average $10.35
▼
-66.8% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 81.8% year-over-year.
- Ranks #72 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2018.
- Lowest revenue per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -2.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.44 | +81.8% |
| FY2024 | $1.89 | -9.2% |
| FY2023 | $2.08 | -20.8% |
| FY2022 | $2.63 | +179.9% |
| FY2021 | $0.94 | -84.1% |
| FY2020 | $5.91 | +1952.9% |
| FY2019 | $0.29 | -95.9% |
| FY2018 | $6.98 | +40529.7% |
| FY2017 | $0.02 | -92.6% |
| FY2016 | $0.23 | -89.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026